Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization and as second year booster: A double-blind, randomized trial
- 1 July 1996
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 1 (1) , 6-13
- https://doi.org/10.1016/s1201-9712(96)90070-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Study of pertussis vaccines in infants: Comparison of response to acellular pertussis DTP vaccines containing 25 μg of FHA and either 25 or 8 μg ofVaccine, 1994
- Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of ageThe Pediatric Infectious Disease Journal, 1993
- Development of an acellular pertussis vaccine and its administration as a booster in healthy adultsVaccine, 1991
- Developments in pertussis immunisation in JapanThe Lancet, 1990
- Comparison of Acellular and Whole-Cell Pertussis-Component DTP VaccinesAmerican Journal of Diseases of Children, 1990
- Progress in worldwide control and elimination of disease through immunizationThe Journal of Pediatrics, 1989
- Pertussis in Sweden after the cessation of general immunization in 1979The Pediatric Infectious Disease Journal, 1987
- Acellular and Whole-Cell Pertussis Vaccines in JapanJAMA, 1987
- Diphtheria, Tetanus, and Pertussis VaccineAmerican Journal of Diseases of Children, 1986
- Pertussis ImmunizationPediatric Annals, 1986